Perimyocarditis Following COVID-19 Vaccination

A 39-year-old male was admitted in the emergency room with chest pain. He had been given the second dose of Pfizer–BioNTech COVID-19 vaccine 3 days before. The patient denied taking any other medication beyond the usual. He didn’t feel sick in the previous days/weeks. Laboratory studies revealed ele...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinoco, Mariana, Leite, Sérgio, Faria, Bebiana, Cardoso, Sara, Von Hafe, Pedro, Dias, Geraldo, Cardoso, Filipa, Pereira, Tamara, Machado, Inocência, Lourenço, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637777/
https://www.ncbi.nlm.nih.gov/pubmed/34866957
http://dx.doi.org/10.1177/11795468211056634
Descripción
Sumario:A 39-year-old male was admitted in the emergency room with chest pain. He had been given the second dose of Pfizer–BioNTech COVID-19 vaccine 3 days before. The patient denied taking any other medication beyond the usual. He didn’t feel sick in the previous days/weeks. Laboratory studies revealed elevated serum levels of troponin and C-reactive protein. An autoantibody screen and a serologic panel to detect common viruses were negative. A cardiac MRI showed myocardial edema/inflammation and confirmed the diagnosis of perimyocarditis which was considered to be a consequence of COVID-19 vaccination. Physicians should be aware of the possibility of cardiovascular complications after COVID-19 vaccination.

Ejemplares similares